COMMUNIQUÉS West-GlobeNewswire

-
The Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California’s Religious Exemption to Vaccination
18/08/2025 -
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
18/08/2025 -
PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations
18/08/2025 -
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
18/08/2025 -
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
18/08/2025 -
WePrevent Launches Florida’s First Comprehensive Prevention Health Platform Amid $100B Chronic Disease Crisis
18/08/2025 -
Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025
18/08/2025 -
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
18/08/2025 -
Sanofi: Information concerning the total number of voting rights and shares - July 2025
18/08/2025 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juillet 2025
18/08/2025 -
Attelia Dental Clinic Wins Prestigious Quality Choice Prize 2025 in Stockholm
18/08/2025 -
Affidea partners with Skin Analytics to improve access to skin cancer assessment across Europe using AI technology
18/08/2025 -
Hapbee Secures Strategic Backing and Commercial Agreement to Enter Multi-Billion Dollar Asian Wellness Market
18/08/2025 -
First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry
18/08/2025 -
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18/08/2025 -
Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.
18/08/2025 -
European Commission Grants Approval of OGSIVEO® (nirogacestat) for the Treatment of Adults with Desmoid Tumors
18/08/2025 -
Elucent Medical Launches SmartSupport™ – A Smarter Standard in Surgical Support
18/08/2025 -
Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
18/08/2025
Pages